Determination of Clopidogrel Sulfate in Pharmaceutical Formulation and Biological Fluids by Extraction Spectrofluorimetric Method
LIAN Wei-qin1, 2, GONG Ai-qin1, 3, WANG Lu1, ZHU Xia-shi1*
1. College of Chemistry & Chemical Engineering, Yangzhou University, Yangzhou 225002, China 2. Jiangdu Secondary Speciallized School of Jiangsu, Yangzhou 225002, China 3. Yangzhou Polytechnic Institute，Yangzhou 225002, China
Abstract：A simple and sensitive spectrofluorimetric method has been developed for the determination of clopidogrel sulfate in pharmaceutical formulation and human urine/ serum. It is based on the formation of ion-pair complex between clopidogrel sulfate and alizarin red in 0.3 mol·L-1 hydrochloric acid solution. The ion pair complex was extracted in dichloromethane and the fluorescence intensity was measured at 550 nm after excitation at 428 nm. The various factors influencing ion-pair complex formation and fluorescence determination were discussed. Under the optimized conditions, the fluorescence value showed a good linear relationship with the clopidogrel sulfate concentration ranging from 1.0 to 11.0 μg·mL-1. The equation of calibration curve was F=53.32+35.01c(μg·mL-1)，r=0.994，and the detection limit was found to be 0.11 μg·mL-1. No interference was observed from common co-existing substances or pharmaceutical excipient. The determination recoveries of clopidogrel sulfate in pharmaceutical formulation and human urine/serum samples were 90.6%～99.3%, 104.6%～109.3%, 96.3%～105.0%, respectively. The method was successfully applied to detect clopidogrel sulfate in clopidogrel sulfate tablet and human urine/ serum. The obtained results of clopidogrel sulfate tablet were in good agreement with the results of HPLC. Therefore, it is concluded that the proposed method is simple, sensitive and rapid for the determination of clopidogrel sulfate in real samples.
[1] AI Xiu-li, LIU Yun, SONG Shuang-shuang, et al(艾秀丽, 刘 韵, 宋双双, 等). Chinese Journal of New Drugs(中国新药杂志), 2012, 21(15): 1812. [2] JIANG Chen, LI Zi-qing, CHEN Xiao-yong(蒋 晨, 李子清, 陈小勇). China J. Pharm.(中国医药工业杂志), 2010, 41(5): 331. [3] LIU Ya-ru, HAN Qiu-yue, LIANG Chen(刘雅茹, 韩秋月, 梁 晨). Chem. Bioengineering(化学与生物工程), 2010, 27(8): 92. [4] GUO Xu-guang, GUO Hai-bo(郭旭光, 郭海波). Strait Pharm. J.(海峡药学), 2012, 24(5): 50. [5] Lü Jie, MENG Xiang-jun, WANG Feng-qiu(吕 洁, 孟祥军, 王凤秋). China Medical Herald(中国医药导报), 2011, 8(9): 60. [6] Kamal Alizadeh, Mahsa Mobarrez, Mohammad Reza Ganjali, et al. Spectrochimica Acta Part A, 2012, 94: 72. [7] Gong Aiqin, Zhu Xiashi. J. Fluoresc., 2013, 23: 1279. [8] Belal F, Sharaf M El-Din, Aly F, et al. J. Fluoresc., 2012, 22: 1141. [9] Nafisur Rahman, Asma Khatoon. Arabian J. Chem., 2012, http://dx.doi.org/10.1016/ j.arabjc., 2012, 01. 005. [10] Chinese Pharmacopoeia Commission(国家药典委员会). Pharmacopoeia of the People’s Republic of China(中华人民共和国药典), 2010. Vol Ⅱ(二部) VD. [11] YE Lei, HU Lu-feng, DU Xiao-xiang(叶 蕾，胡卢丰，杜晓翔). Medical Herald(医药导报), 2011, 30(12): 1651.
